Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Heterogeneous nuclear ribonucleoprotein A3 pseudogene 10 (HNRNPA3P10) is a noncoding pseudogene located on human chromosome 12, with no evidence of protein product or function. It is listed in genetic databases and referenced by genomic position and accession numbers, but it does not encode an active heterogeneous nuclear ribonucleoprotein A3 nor participate in molecular pathways known to be pharmacologically actionable[1][3][7][9][11]. Its main relevance is for genetic annotation and reference purposes; no biomedical or therapeutic role is established. This distinguishes it from functional members of the heterogeneous nuclear ribonucleoprotein family such as hnRNPA3, which does have documented biological and disease roles[2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Heterogeneous nuclear ribonucleoprotein A3 pseudogene 10 (HNRNPA3P10).